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Abstract
Background Chronic pain patients increasingly seek treat-
ment through mindfulness meditation.
Purpose This study aims to synthesize evidence on efficacy
and safety of mindfulness meditation interventions for the
treatment of chronic pain in adults.
Method We conducted a systematic review on randomized
controlled trials (RCTs) with meta-analyses using the
Hartung-Knapp-Sidik-Jonkman method for random-effects
models. Quality of evidence was assessed using the GRADE
approach. Outcomes included pain, depression, quality of life,
and analgesic use.
Results Thirty-eight RCTs met inclusion criteria; seven re-
ported on safety. We found low-quality evidence that mind-
fulness meditation is associated with a small decrease in pain
compared with all types of controls in 30 RCTs. Statistically
significant effects were also found for depression symptoms
and quality of life.
Conclusions While mindfulness meditation improves pain
and depression symptoms and quality of life, additional
well-designed, rigorous, and large-scale RCTs are needed to
decisively provide estimates of the efficacy of mindfulness
meditation for chronic pain.
Keywords Chronic pain .Mindfulness .Meditation .
Systematic review
Introduction
Chronic pain, often defined as pain lasting longer than
3 months or past the normal time for tissue healing [1], can
lead to significant medical, social, and economic conse-
quences, relationship issues, lost productivity, and larger
health care costs. The Institute of Medicine recognizes pain
as a significant public health problem that costs our nation at
least $560–635 billion annually, including costs of health care
and lost productivity [2]. Further, chronic pain is frequently
accompanied by psychiatric disorders such as pain medication
addiction and depression that make treatment complicated [3].
The high prevalence and refractory nature of chronic pain, in
conjunction with the negative consequences of pain medica-
tion dependence, has led to increased interest in treatment
plans that include adjunctive therapy or alternatives to medi-
cation [4]. One such modality that pain patients are using is
mindfulness meditation. Based on ancient Eastern meditation
practices, mindfulness facilitates an attentional stance of de-
tached observation. It is characterized by paying attention to
the present moment with openness, curiosity, and acceptance
[5, 6]. Mindfulness meditation is thought to work by
refocusing the mind on the present and increasing awareness
of one’s external surroundings and inner sensations, allowing
the individual to step back and reframe experiences. Current
research using neuroimaging to elucidate neurological mech-
anisms underlying effects of mindfulness has focused on brain
structures such as the posterior cingulate cortex, which appear
to be involved in self-referential processing [7, 8]. Clinical
uses of mindfulness include applications in substance abuse
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[9], tobacco cessation [10], stress reduction [11], and treat-
ment of chronic pain [12–14].
Early mindfulness studies in pain patients showed promis-
ing outcomes on pain symptoms, mood disturbance, anxiety,
and depression, as well as pain-related drug utilization [5].
Numerous systematic reviews on the effects of mindfulness
meditation have been published in recent years. Of those that
report pain outcomes, several have focused on specific types
of pain such as low back pain [13], fibromyalgia [15], or
somatization disorder [16]. Others were not limited to RCTs
[14, 17]. There have been several comprehensive reviews fo-
cused on controlled trials of mindfulness interventions for
chronic pain including a review [4] that showed improve-
ments in depressive symptoms and coping, another review
[18] on mindfulness for chronic back pain, fibromyalgia,
and musculoskeletal pain that showed small positive effects
for pain, and the most recent review [19] on various pain
conditions which found improvements in pain, pain accep-
tance, quality of life, and functional status. Authors of these
reviews echoed concerns that there is limited evidence for
efficacy of mindfulness-based interventions for patients with
chronic pain because of methodological issues. They have
concluded that additional high-quality research was needed
before a recommendation for the use of mindfulness medita-
tion for chronic pain symptoms could be made.
The purpose of this study was to conduct a systematic re-
view and meta-analysis of the effects and safety of mindfulness
meditation, as an adjunctive or monotherapy to treat individ-
uals with chronic pain due to migraine, headache, back pain,
osteoarthritis, or neuralgic pain compared with treatment as
usual, waitlists, no treatment, or other active treatments. Pain
was the primary outcome, and secondary outcomes included
depression, quality of life, and analgesic use. The systematic
review protocol is registered in an international registry for
systematic reviews (PROSPERO 2015:CRD42015025052).
Methods
Search Strategy
We searched the electronic databases PubMed, Cumulative
Index to Nursing and Allied Health Literature (CINAHL),
PsycINFO, and Cochrane Central Register of Controlled
Trials (CENTRAL) for English-language-randomized con-
trolled trials from inception through June 2016. We combined
pain conditions and design terms with the following mindful-
ness search terms: “Mindfulness” [Mesh]) or “Meditation”
[Mesh] or mindfulness* or mindfulness-based or MBSR or
MBCT or M-BCT or meditation or meditat* or Vipassana or
satipaṭṭhāna or anapanasati or Zen or Pranayama or Sudarshan
or Kriya or zazen or shambhala or buddhis*.” In addition to
this search and the reference mining of all included studies
identified through it, we reference mined prior systematic re-
views and retrieved all studies included therein.
Eligibility Criteria
Parallel group, individual or cluster RCTs of adults who report
chronic pain were included. Studies where the author defined
chronic pain and studies in patients reporting pain for a min-
imum of 3 months were included. Studies were required to
involve mindfulness meditation, either as an adjunctive or
monotherapy; studies testing other meditation interventions
such as yoga, tai chi, qigong, and transcendental meditation
techniques without reference to mindfulness were excluded.
Mindfulness interventions that did not require formal medita-
tion, such as acceptance and commitment therapy (ACT) were
also excluded. Only studies that reported pain measures or
change in analgesic use were included. Dissertations and con-
ference abstracts were excluded.
Procedures
Two independent reviewers screened titles and abstracts of
retrieved citations—following a pilot session to ensure similar
interpretation of the inclusion and exclusion criteria. Citations
judged as potentially eligible by one or both reviewers were
obtained as full text. The full text publications were then du-
ally screened against the specified inclusion criteria. The flow
of citations throughout this process was documented in an
electronic database, and reasons for exclusion of full-text pub-
lications were recorded. Data abstraction was also conducted
in dual. Risk of bias was assessed using the Cochrane Risk of
Bias tool [20]. Other biases related to the US Preventive
Services Task Force’s (USPSTF) criteria for internal validity
of included studies were assessed [21, 22]. These criteria were
used to rate the quality of evidence as good, fair, or poor for
each included study.
Meta-analytic Techniques
When sufficient data were available and statistical heteroge-
neity was below agreed thresholds [20], we performed meta-
analysis to pool efficacy results across included studies for the
outcomes of interest and present a forest plot for the main
meta-analysis. We used the Hartung-Knapp-Sidik-Jonkman
method for random effects meta-analysis using unadjusted
means and measures of dispersion [23–25]. For studies
reporting multiple pain outcomes, we used specific pain mea-
sures, such as the McGill Pain Questionnaire (MPQ) for the
main meta-analysis rather than the pain subscale of the SF-36,
and average or general pain measures rather than situational
measures such as pain at the time of assessment. Due to the
small number of adverse events reported, quantitative analysis
was not conducted. We conducted subgroup analyses and
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meta-regressions to address whether there were differences in
effect sizes between different interventions types, populations,
or when used as monotherapy versus an adjunctive therapy.
The quality of the body of evidence was assessed using the
GRADE approach [22, 26] by which a determination of high,
moderate, low, or very low was made for each major outcome
[27].
Results
Description of Included Studies
We identified 744 citations through searches of electronic da-
tabases and 11 additional records identified through other
sources (see Fig. 1). Full texts were obtained for 125 citations
identified as potentially eligible by two independent re-
viewers; 38 RCTs met inclusion criteria. Details of study char-
acteristics are displayed in Table 1 and effects for individual
studies are displayed in Table 2.
In total, studies assigned 3536 participants; sample sizes
ranged from 19 to 342. Fifteen studies reported an a priori
power calculation with targeted sample size achieved, ten
studies did not report information about a power calculation,
and three studies were unclear in the reporting of a power
calculation. Ten studies noted there was insufficient power;
the authors considered these pilot studies. The majority of
the studies were conducted in North America or Europe.
The mean age of participants ranged from 30 (SD, 9.08) to
78 years (SD, 7.1. Eight studies included only female
participants.
Medical conditions reported included fibromyalgia in eight
studies and back pain in eight studies. (Categories are not
mutually exclusive; some studies included patients with dif-
ferent conditions.) Osteoarthritis was reported in two studies
and rheumatoid arthritis in three. Migraine headache was re-
ported in three studies and another type of headache in five
studies. Three studies reported irritable bowel syndrome
(IBS). Eight studies reported other causes of pain and three
studies did not specify a medical condition or source of chron-
ic pain.
The total length of the interventions ranged from 3 to
12 weeks; the majority of interventions (29 studies) were
8 weeks in length. Twenty-one studies were conducted on
mindfulness-based stress reduction (MBSR) and six on
mindfulness-based cognitive therapy (MBCT). Eleven addi-
tional studies reported results on other types of mindfulness
training. Thirteen RCTs provided the mindfulness interven-
tion as monotherapy, and eighteen utilized a mindfulness in-
tervention as adjunctive therapy, specifying that all partici-
pants received this in addition to other treatment such as med-
ication. Seven of the studies were unclear as to whether the
mindfulness intervention was monotherapy or adjunctive ther-
apy. Nineteen RCTs used treatment as usual as comparators,
thirteen used passive comparators, and ten used education/
support groups as comparators. Beyond these common com-
parators, one study each used stress management, massage, a
multidisciplinary pain intervention, relaxation/stretching, and
nutritional information/food diaries as comparators; two stud-
ies used cognitive-behavioral therapy. Several studies had two
comparison arms.
Study Quality and Risk of Bias
The study quality for each included study is displayed in
Table 1. Eleven studies obtained a “good” quality rating
[28–38]. Fourteen studies were judged to be of fair quality,
primarily due to being unclear in some aspects of the methods
[39–52]. Thirteen studies were judged to be poor; ten primar-
ily due to issues with completeness of reporting outcome data
such as inadequate or missing intention to treat (ITT) analysis
and/or less than 80 % follow-up [53–62] and three due to
unclear methods [63–65]. Details of the quality ratings and
risk of bias for each included study is displayed in
Electronic Supplementary Material 1.Fig. 1 Literature flow diagram
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Measures
Studies reported patient pain measures such as the Visual
Analog Scale, the SF-36 pain subscale, and McGill Pain
Questionnaire. Secondary outcomemeasures included depres-
sion symptoms (e.g., Beck Depression Inventory, Patient
Health Questionnaire), physical and mental health-related
quality of life (e.g., SF-36 mental and physical components),
and functional impairment/disability (e.g., Roland-Morris
Disability Questionnaire, Sheehan Disability Scale).
Chronic Pain Treatment Response
Thirty RCTs reported continuous outcome data on scales
assessing chronic pain [29, 31–33, 36, 39–49, 51–60, 62–64,
66].
Eight studies met screening inclusion criteria but did not
contribute to the meta-analysis because they did not report
poolable data [28, 30, 34, 35, 38, 50, 61, 65]. Their study
characteristics are displayed in Table 1, and study level effects
along with the reasons they were not in pooled analyses are
displayed in Table 2.
Pain scales and comparators varied from study to study.
The median follow-up time was 12 weeks, with a range of
4 to 60 weeks. Figure 2 displays the results of meta-
analysis using data at the longest follow-up for each study.
The pooled analysis indicates a statistically significant ef-
fect of mindfulness meditation compared with treatment as
usual, passive controls, and education/support groups
(SMD, 0.32; 95 % CI, 0.09, 0.54; 30 RCTs). Substantial
heterogeneity was detected (I2 = 77.6 %). There was no
evidence of publication bias (Begg’s p = 0.26; Egger’s test
p = 0.09). To investigate whether the treatment estimate is
robust when excluding poor-quality studies and to explore
the possible source of the substantial heterogeneity, we con-
ducted a sensitivity analysis including only fair or good
quality studies. The improvement remained significant, the
effect size was smaller (SMD, 0.19; 95 % CI, 0.03, 0.34;
19 RCTs), and there was less heterogeneity (I2 = 50.5 %).
Meta-regressions showed that changes in pain outcomes in
good- (p = 0.42) and fair-quality (p = 0.13) studies were
not significantly different from changes in poor-quality
studies.
In subgroup analyses, the effect was not statistically sig-
nificant at 12 weeks or less (SMD, 0.25; 95 % CI, −0.13,
0.63; 15 RCTs; I2 = 82.6 %) but was significant for follow-
up periods beyond 12 weeks (SMD, 0.31; 95 % CI, 0.04,
0.59; 14 RCTs, I2 = 69.0 %). Begg’s test was not statisti-
cally significant (p = 0.16) but Egger’s test showed evi-
dence of publication bias (p = 0.04). The quality of evi-
dence that mindfulness meditation is associated with a de-
crease in chronic pain compared with control is low overall
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inconsistency, heterogeneity, and possible publication bias.
A detailed table displays the quality of evidence for find-
ings for each major outcome in Electronic Supplementary
Material 2.
In order to present clinically meaningful results, we
calculated the percent change in pain symptoms from
baseline to follow-up for mindfulness meditation and
comparison groups for each study and displayed find-
ings in Table 2. We then calculated the overall weighted
mean percent change for mindfulness meditation groups
versus comparison groups for effects of meditation for
pain at longest follow-up. The mean percent change in
pain for meditation groups was −0.19 % (SD, 0.91;
min, −0.48; max, 0.10) while the mean percent change
in pain for control groups was −0.08 % (SD, 0.74; min,
−0.35; max, 0.11). The p value for the difference be-
tween groups was significant (p = 0.0031).
Depression
Depression outcomes were reported in 12 RCTs [29, 31, 33,
34, 45, 46, 48, 49, 51–53, 56]. Overall, meditation significant-
ly lowered depression scores as compared with treatment as
usual, support, education, stress management, and waitlist
control groups (SMD, 0.15; 95 % CI, 0.03, 0.26; 12 RCTs;
I2 = 0 %). No heterogeneity was detected. The quality of
evidence was rated as high due to lack of heterogeneity, con-
sistent study results, and precision of effect (small confidence
intervals).
Quality of Life
Sixteen studies reported mental health-related quality of
life; the effect of mindfulness meditation was significant
in the pooled analysis as compared with treatment as
usual, support groups, education, stress management,
and waitlist controls (SMD, 0.49; 95 % CI, 0.22, 0.76;
I2, 74.9 %). [32–34, 45–49, 52, 54, 56, 59, 60, 62–64].
Sixteen studies measured physical health-related quality
of life [32–34, 36, 45–49, 52, 54, 56, 60, 62–64].
Pooled analyses showed a significant effect of mindful-
ness meditation as compared with treatment as usual,
support groups, education, stress management, and
waitlist controls (SMD, 0.34; 95 % CI, 0.03, 0.65; I2,
79.2 %). Both quality-of-life analyses detected substan-
tial heterogeneity, and the quality of evidence was rated
as moderate for mental health (small confidence
Fig. 2 Mindfulness meditation
effects on chronic pain
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intervals, more consistent results) and low for physical
health-related quality of life.
Functional Impairment (Disability Measures)
Four studies reported poolable disability scores from the
Roland-Morris Disability Questionnaire and the Sheehan
Disability Scale [33, 36, 47, 55]. The difference be-
tween the mindfulness and comparison groups in
follow-up was not statistically significant (SMD, 0.30;
95 % CI, −0.02, 0.62; I2 = 1.7 %), although the results
approached significance. No heterogeneity was detected.
The quality of evidence was rated low due to impreci-
sion and small total sample size.
Analgesic Use
Only four studies reported use of analgesics as an out-
come. In a study of MBSR for treatment of chronic
pain due to failed back surgery syndrome [55], at 12-
week follow-up, the analgesic medication logs of the
intervention group documented a decrease in analgesic
use compared with those in the control group (−1.5
(SD = 1.8) vs. 0.4 (SD = 1.1), p = <0.001). A study
of mindfulness meditation and cognitive-behavioral ther-
apy vs. usual care for low back pain [35] reported that
the mean morphine equivalent dose (mg/day) of opioids
was not significantly different between groups at both 8
and 26 weeks. Likewise, a trial of MBSR for back pain
[38] found no significant difference between groups in
self-reported use of pain medication. Finally, a trial of
mindfulness-oriented recovery enhancement (MORE) for
chronic pain of various etiologies [44] found interven-
tion participants significantly more likely to no longer
meet criteria for opioid use disorder immediately fol-
lowing treatment (p = 0.05); however, these effects were
not sustained at 3-month follow-up.
Adverse Events
Only 7 of the 38 included RCTs reported on adverse events.
Four stated no adverse events occurred [36, 47, 50, 57]; one
described that two participants experienced temporary strong
feelings of anger toward their pain condition and two of the
participants experienced greater anxiety [46]; two studies re-
corded mild side effects from yoga and progressive muscle
relaxation [35, 38].
Study Characteristic Moderators
Meta-regressions were run to determine if changes in
pain outcomes systematically differed by several subcat-
egories. There was no difference in effect on pain
between MBSR (16 studies) and MBCT (4 studies;
p = 0.68) or other types of mindfulness interventions
(10 studies; p = 0.68). When comparing MBSR (16
studies) to all other interventions (14 studies), there
was also no difference in effect (p = 0.45). As stated
in more detail above, medical conditions reported in-
cluded fibromyalgia, back pain, arthritis, headache, and
irritable bowel syndrome (IBS). Meta-regressions did
not suggest differences between headache (six studies)
and other conditions (p = 0.93), back pain (eight stud-
ies) and other conditions (p = 0.15), and fibromyalgia
(eight studies) and other conditions (p = 0.29). Gender
composition (% male) had no association with effect on
pain (p = 0.26). The total length of the intervention
program ranged from 3 to 12 weeks (mean was
8 weeks). Meta-regression did not suggest differences
between high-frequency interventions and medium-
(p = 0.16) or low-frequency (p = 0.44) interventions.
No systematic difference in effect on pain between ad-
junctive therapy and monotherapy (p = 0.62) or between
adjunctive therapy and interventions where this was un-
clear (p = 0.10) was found. Finally, there was no sys-
tematic difference in effect whether the comparator was
treatment as usual, waitlist, or another intervention
(p = 0.21).
Discussion
In sum, mindfulness meditation was associated with a
small effect of improved pain symptoms compared with
treatment as usual, passive controls, and education/
support groups in a meta-analysis of 30 randomized
controlled trials. However, there was evidence of sub-
stantial heterogeneity among studies and possible publi-
cation bias resulting in a low quality of evidence. The
efficacy of mindfulness meditation on pain did not dif-
fer systematically by type of intervention, medical con-
dition, or by length or frequency of intervention.
Mindfulness meditation was associated with statistically
significant improvement in depression, physical health-
related quality of life, and mental health-related quality
of life. Quality of evidence was high for depression,
moderate for mental health-related quality of life, and
low for physical health-related quality of life. Only four
studies reported on change in analgesic use; results were
mixed. Adverse events in the included RCTs were rare
and not serious, but the vast majority of studies did not
collect adverse events data.
This review has several methodological strengths: an
a priori research design, duplicate study selection and
data abstraction of study information, a comprehensive
search of electronic databases, risk of bias assessments,
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and comprehensive quality of evidence assessments used
to formulate review conclusions. One limitation is that
we did not contact individual study authors; results re-
ported in the review are based on published data. We
excluded conference abstracts which do not contain
enough data to evaluate study quality. In addition, we
included only studies published in English.
The included studies had many limitations. Thirteen of the
thirty-eight studies were rated as poor quality, primarily due to
lack of ITT, poor follow-up, or poor reporting of methods for
randomization and concealment of allocation. The authors of
ten studies reported inadequate statistical power to detect dif-
ferences in pain outcomes between mindfulness meditation
and the comparator; the authors considered these pilot studies.
Ten other studies did not report a power calculation. Sample
sizes were small; 15 studies randomized fewer than 50
participants.
More well-designed, rigorous, and large RCTs are need-
ed in order to develop an evidence base that can more
decisively provide estimates of its effectiveness. Studies
should enroll samples large enough to detect statistical
differences in outcomes and should follow-up with partic-
ipants for 6 to 12 months in order to assess the long-term
effects of meditation. Adherence to mindfulness practice
and simultaneous use of other therapies should be moni-
tored frequently. Intervention characteristics, including the
optimal dose, have also not yet conclusively been
established. In order to detect intervention specific effects,
studies need to have attention-matched controls. Smaller
trials may be conducted to answer these questions. Other
outcomes that were outside the scope of this review may
be important to explore. As the impact of mindfulness
may be related to the appraisal of the pain, it may be
useful for future trials to focus primary outcomes on
symptoms associated with pain such as quality of life,
pain-related interference, pain tolerance, analgesic, and re-
lated issues such as opioid craving. Future publications on
RCTs of mindfulness meditation should adhere to
Consolidated Standards of Reporting Trials (CONSORT)
standards.
Only three RCTs attributed minor adverse events to
mindfulness meditation. However, only 7 of the 38 in-
cluded RCTs mentioned whether adverse events were
monitored and collected. Thus quality of evidence for
adverse events reported in RCTs is inadequate for a
comprehensive assessment. Given published reports of
adverse events during meditation, including psychosis
[67], future trials should actively collect adverse events
data. In addition, a systematic review of observational
studies and case reports would shed additional light on
adverse events during mindfulness meditation.
Further research examining the effect of mindfulness
meditation on chronic pain should also focus on better
understanding whether there is a minimum frequency or
duration of meditation practice for it to be effective.
While recent studies have yielded similar positive ef-
fects of mindfulness for pain, these effects tend to be
small to medium and based on a body of evidence that
is, at best, of moderate quality. A potential way to ad-
vance research on chronic pain would be to improve
intervention and control group descriptions, identify dif-
ferent effects of various components of complex inter-
ventions, and work toward a standard criterion for
assessing therapeutic gain [68]. Head-to-head trials that
compare mindfulness interventions of a similar category
but with variations in components or dose may be help-
ful to tease out the most effective elements of these
interventions [69].
Similar to previous reviews in this area, we conclude
that while mindfulness meditation interventions showed
significant improvements for chronic pain, depression,
and quality of life, the weaknesses in the body of evi-
dence prevent strong conclusions. The available evi-
dence did not yield consistent effects for pain outcomes,
and few studies were available for forms of mindfulness
meditation other than MBSR. Quality of evidence for
the efficacy of mindfulness interventions in reducing
chronic pain is low. There was higher quality evidence
of the efficacy of mindfulness meditation on depression
and mental health-related quality-of-life outcomes. This
review is consistent with previous reviews concluding
that more well-designed, rigorous, and large RCTs are
needed in order to develop an evidence base that can
more decisively provide estimates of the efficacy of
mindfulness meditation for chronic pain. In the mean-
time, chronic pain continues to pose a tremendous bur-
den on society and individuals. A novel therapeutic ap-
proach for chronic pain management such as mindful-
ness meditation would likely be welcomed by patients
suffering from pain.
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